Medical University of Ohio at Toledo

Medical University of Ohio at Toledo was paid $50.84M by Medicaid between Jan 2018 and Dec 2024, across 507 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 31% of everything it billed.

33Billing provider infoMEDICAL UNIVERSITY OF OHIO AT TOLEDO
TOLEDO, OH 43614

33aNPI1811971302assigned 11/30/2005

33bProvider typeClinic/Center

28Total paid$50.84M

24GClaims1,399,339

24DCodes billed507

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinic/Center providers in Ohio

Rank by total paid#1 of 70

Median peer was paid$140K

This provider vs. median364×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	104,460	$4.70M
2019	108,822	$4.53M
2020	89,303	$4.59M
2021	107,680	$5.61M
2022	158,323	$6.25M
2023	485,759	$15.03M
2024incomplete	344,992	$10.14M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	31%	161,314	128,111	$15.52M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.1%	38,214	33,319	$4.64M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	6.1%	26,964	24,778	$3.10M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.6%	25,238	22,937	$2.86M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.8%	18,126	14,166	$2.42M
96361	Intravenous infusion, hydration; each additional hour	3.4%	6,300	3,303	$1.70M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.0%	24,616	6,899	$1.54M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.2%	9,363	7,811	$1.13M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.7%	3,515	2,459	$884K
90837	Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient	1.6%	8,822	4,814	$822K
70450	Computed tomography, head or brain; without contrast material	1.5%	4,681	3,427	$787K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	5,586	3,236	$611K

495 more codes

G0378	Hospital observation service, per hour	1.0%	10,114	$520K
80053	Comprehensive metabolic panel	<1%	41,630	$477K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	2,881	$450K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,227	$398K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,760	$389K
20610		<1%	2,739	$383K
92551		<1%	4,335	$376K
96127		<1%	2,634	$340K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,987	$326K
H0015	Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education	<1%	3,278	$290K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,183	$268K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,748	$243K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,228	$241K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,144	$241K
80048	Basic metabolic panel (calcium, ionized)	<1%	32,533	$240K
96415		<1%	1,001	$238K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,283	$221K
90834	Psychotherapy session, about 45 minutes	<1%	2,437	$206K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	67,194	$200K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	10,179	$191K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	588	$188K
97010		<1%	6,660	$181K
J0485	Injection, belatacept, 1 mg	<1%	631	$179K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	371	$176K
H0036	Community psychiatric support and treatment, per 15 minutes	<1%	3,689	$170K
86359		<1%	5,490	$163K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	348	$157K
90792	Psychiatric diagnostic evaluation with medical services	<1%	889	$148K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	2,391	$143K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	841	$138K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	10,177	$135K
87536		<1%	5,627	$133K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,225	$133K
76000		<1%	1,531	$126K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,922	$123K
36415	Collection of venous blood by venipuncture	<1%	116,664	$122K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	5,188	$116K
Q3014	Telehealth originating site facility fee	<1%	4,526	$116K
84443	Thyroid stimulating hormone (TSH)	<1%	11,384	$115K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	547	$109K
80061	Lipid panel	<1%	12,593	$106K
97162		<1%	1,736	$95K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	619	$94K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	846	$93K
83021		<1%	9,819	$92K
64493		<1%	138	$89K
86592		<1%	5,499	$86K
95886		<1%	645	$83K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,017	$82K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	884	$81K
97113		<1%	1,134	$78K
97161		<1%	1,564	$72K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	1,411	$72K
96367		<1%	1,289	$71K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	23,290	$69K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	3,747	$68K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	5,291	$67K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,302	$67K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	799	$65K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,423	$63K
93798		<1%	1,092	$62K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	556	$62K
86360		<1%	3,372	$60K
97165		<1%	964	$59K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	619	$55K
71046	Radiologic examination, chest; 2 views	<1%	5,135	$54K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	248	$51K
72141		<1%	338	$51K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,296	$49K
71250		<1%	666	$48K
94060		<1%	465	$47K
97535	Self-care/home management training, each 15 minutes	<1%	1,987	$47K
93970		<1%	425	$46K
82607		<1%	3,469	$46K
93017		<1%	710	$45K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	18,602	$44K
84484		<1%	14,810	$43K
87660		<1%	5,981	$42K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,110	$42K
87480		<1%	5,909	$42K
84439		<1%	3,200	$42K
71045	Radiologic examination, chest; single view	<1%	9,254	$42K
86850		<1%	2,146	$42K
93975		<1%	668	$41K
71271		<1%	313	$41K
90791	Psychiatric diagnostic evaluation	<1%	362	$41K
85027		<1%	10,263	$41K
83735		<1%	16,771	$40K
73221		<1%	212	$39K
87510		<1%	5,893	$39K
86140		<1%	3,921	$39K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	685	$38K
76770		<1%	316	$38K
87640		<1%	2,107	$38K
73610		<1%	2,574	$37K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	235	$37K
76536		<1%	399	$36K
73562		<1%	2,353	$35K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	7,156	$33K
17110		<1%	213	$33K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	316	$33K
72100		<1%	1,586	$32K
J3490	Unclassified drugs	<1%	2,307	$32K
86900		<1%	2,291	$30K
99204	Doctor's office visit, new patient (more involved)	<1%	272	$30K
70496		<1%	187	$30K
82728		<1%	2,735	$28K
87086	Culture, bacterial; quantitative colony count, urine	<1%	5,069	$28K
80305		<1%	2,250	$28K
72131		<1%	505	$28K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,442	$28K
64483		<1%	46	$27K
97166		<1%	726	$27K
90677		<1%	300	$27K
90686		<1%	2,354	$27K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,133	$27K
99215	Doctor's office visit, returning patient (complex)	<1%	240	$27K
90832	Psychotherapy session, about 30 minutes	<1%	421	$26K
78815	Positron emission tomography (PET) for limited area imaging	<1%	54	$26K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,814	$26K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,451	$26K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	3,285	$26K
74183		<1%	118	$26K
20550		<1%	179	$25K
73630		<1%	2,252	$25K
80320		<1%	3,161	$24K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	12,975	$24K
93971		<1%	339	$24K
97163		<1%	371	$23K
73030		<1%	1,857	$23K
87641		<1%	2,126	$22K
85610		<1%	17,139	$22K
94729		<1%	448	$22K
62370		<1%	322	$21K
97116		<1%	936	$21K
80076		<1%	4,654	$21K
86803		<1%	2,113	$21K
76830	Ultrasound, transvaginal	<1%	676	$21K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	43	$20K
76937		<1%	1,665	$19K
83540		<1%	3,312	$19K
94726		<1%	364	$19K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	270	$19K
36000		<1%	1,033	$19K
73502		<1%	1,312	$19K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,202	$19K
87340		<1%	2,062	$18K
36592		<1%	999	$18K
73130		<1%	1,702	$18K
80197		<1%	2,619	$18K
86480		<1%	705	$18K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	1,882	$17K
H2020	Therapeutic behavioral services, per diem	<1%	396	$17K
93299		<1%	529	$17K
74018		<1%	1,017	$17K
87077		<1%	3,610	$17K
77300		<1%	50	$17K
72110		<1%	1,192	$16K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	188	$16K
90715		<1%	1,153	$16K
64635		<1%	21	$16K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	33	$15K
82570		<1%	3,192	$15K
82805		<1%	622	$15K
99385		<1%	158	$15K
77336		<1%	216	$15K
95117		<1%	718	$15K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,293	$14K
83550		<1%	2,778	$14K
72050		<1%	773	$14K
73110		<1%	1,145	$14K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	70	$13K
82947		<1%	17,729	$13K
97035		<1%	272	$13K
85651		<1%	4,134	$12K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	72	$12K
86038		<1%	991	$12K
93454		<1%	13	$12K
0002A		<1%	409	$12K
84100		<1%	6,560	$12K
0001A		<1%	407	$11K
81001		<1%	10,663	$11K
76642		<1%	117	$11K
84403		<1%	1,066	$11K
84153		<1%	1,019	$11K
70498		<1%	215	$10K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	18	$10K
81003		<1%	10,884	$10K
43235		<1%	30	$10K
83880		<1%	2,526	$10K
72040		<1%	631	$10K
82248		<1%	2,740	$10K
84481		<1%	1,134	$9K
73564		<1%	339	$9K
82746		<1%	1,387	$9K
83970		<1%	694	$9K
84702		<1%	740	$9K
J0897	Injection, denosumab, 1 mg	<1%	13	$9K
93296		<1%	354	$9K
93922		<1%	160	$9K
64721		<1%	22	$8K
87799		<1%	1,034	$8K
83605		<1%	5,060	$8K
99152		<1%	1,417	$8K
86706		<1%	648	$8K
94799		<1%	900	$8K
64415		<1%	37	$8K
83516		<1%	754	$8K
87070		<1%	1,780	$8K
77334		<1%	14	$8K
85730		<1%	7,040	$8K
87522	Neg quan hep c or qual rna	<1%	355	$7K
80164		<1%	576	$7K
99203	Doctor's office visit, new patient (routine)	<1%	79	$7K
83690		<1%	6,844	$7K
86901		<1%	2,288	$7K
70486		<1%	487	$7K
87497		<1%	442	$7K
83883		<1%	511	$7K
84550		<1%	3,613	$7K
96523		<1%	199	$7K
87186		<1%	2,417	$7K
86704		<1%	738	$7K
86481		<1%	473	$7K
73590		<1%	654	$6K
81025		<1%	8,896	$6K
73560		<1%	865	$6K
82043		<1%	1,533	$6K
83036	Hemoglobin; glycosylated (A1C)	<1%	970	$6K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	3,237	$6K
20611		<1%	19	$6K
96116		<1%	34	$6K
99386		<1%	63	$5K
J1756	Injection, iron sucrose, 1 mg	<1%	524	$5K
70491		<1%	24	$5K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	2,490	$5K
84270		<1%	704	$5K
74022		<1%	291	$5K
82784		<1%	646	$5K
72170		<1%	887	$5K
73080		<1%	405	$5K
82140		<1%	694	$4K
86431		<1%	584	$4K
86160		<1%	735	$4K
82550		<1%	1,217	$4K
73552		<1%	459	$4K
77080		<1%	81	$4K
88142		<1%	290	$4K
82565		<1%	941	$4K
95908		<1%	29	$4K
78264		<1%	20	$4K
00731		<1%	1,047	$4K
84156		<1%	1,499	$4K
86695		<1%	116	$4K
86200		<1%	440	$4K
95806		<1%	56	$3K
76981		<1%	43	$3K
96368		<1%	335	$3K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	13,465	$3K
80329		<1%	897	$3K
84146		<1%	534	$3K
88172		<1%	47	$3K
86225		<1%	448	$3K
90836		<1%	28	$3K
72072		<1%	179	$3K
86235		<1%	360	$3K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	13,033	$3K
J2704	Injection, propofol, 10 mg	<1%	11,479	$3K
77065	Tomosynthesis, mammo	<1%	101	$3K
96375	Therapeutic injection; each additional sequential IV push	<1%	7,502	$3K
99153	Mod sedat endo service >5yrs	<1%	571	$3K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	34	$3K
96376		<1%	2,549	$2K
86762		<1%	203	$2K
85378		<1%	1,855	$2K
73090		<1%	248	$2K
94618		<1%	43	$2K
57454		<1%	12	$2K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	12	$2K
93270		<1%	41	$2K
74174		<1%	27	$2K
86832		<1%	412	$2K
86833		<1%	412	$2K
82977		<1%	518	$2K
87040		<1%	1,288	$2K
73120		<1%	153	$2K
86787		<1%	144	$2K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	3,158	$2K
J7030	Infusion, normal saline solution , 1000 cc	<1%	10,854	$2K
82670		<1%	106	$2K
99406		<1%	91	$2K
96138		<1%	36	$2K
87506		<1%	14	$2K
93880		<1%	29	$2K
77002		<1%	108	$2K
96133		<1%	43	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,680	$2K
81002		<1%	4,349	$2K
83001		<1%	189	$2K
86696		<1%	128	$2K
00811		<1%	303	$1K
73700		<1%	14	$1K
86593		<1%	160	$1K
88304		<1%	220	$1K
H2012	Behavioral health day treatment, per hour	<1%	25	$1K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	7,212	$1K
82330		<1%	818	$1K
87205		<1%	931	$1K
90674		<1%	69	$1K
84703		<1%	480	$1K
86780		<1%	172	$1K
93799		<1%	81	$1K
92523		<1%	21	$1K
84520		<1%	506	$1K
90630		<1%	49	$1K
36416		<1%	8,120	$1K
C1889	Implantable/insertable device, not otherwise classified	<1%	1,573	$1K
84165		<1%	210	$1K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	173	$997.96
29581		<1%	16	$993.66
73060		<1%	90	$987.08
90682		<1%	51	$973.31
82533		<1%	92	$959.31
82040		<1%	250	$956.53
82785		<1%	136	$946.74
88342		<1%	1,288	$937.24
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,251	$935.71
86376		<1%	125	$907.69
86003		<1%	64	$906.80
97012		<1%	28	$888.56
90651		<1%	131	$888.08
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,085	$860.26
96132		<1%	34	$853.33
83520		<1%	79	$853.19
84132		<1%	420	$829.42
86920		<1%	89	$829.05
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,064	$825.33
87081		<1%	70	$824.03
90688		<1%	47	$793.02
J1644	Injection, heparin sodium, per 1000 units	<1%	5,581	$782.54
83615		<1%	186	$775.01
85018		<1%	505	$762.16
82105		<1%	136	$740.38
01810		<1%	266	$735.70
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,075	$727.78
94762		<1%	179	$725.62
80299		<1%	246	$704.31
J1815	Injection, insulin, per 5 units	<1%	1,215	$683.70
90662		<1%	88	$680.13
83993		<1%	32	$662.75
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	9,376	$660.18
83002		<1%	60	$636.79
84145		<1%	215	$635.71
84425		<1%	111	$563.57
29125		<1%	229	$533.95
82150		<1%	48	$528.30
90461		<1%	252	$518.05
90670		<1%	68	$497.50
00813		<1%	270	$492.08
82525		<1%	69	$479.91
J7050	Infusion, normal saline solution, 250 cc	<1%	13,329	$478.92
83874		<1%	164	$462.52
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	198	$459.18
84460		<1%	184	$449.15
83525		<1%	50	$448.56
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	7,779	$425.59
87109		<1%	17	$396.02
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,574	$370.59
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	54	$361.90
72080		<1%	15	$345.20
82272		<1%	119	$328.86
96139		<1%	14	$326.34
90633		<1%	38	$323.25
84450		<1%	113	$316.56
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	653	$315.00
72128		<1%	32	$295.14
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	31	$288.50
84207		<1%	52	$286.43
J3370	Injection, vancomycin hcl, 500 mg	<1%	941	$277.00
80047		<1%	15	$270.36
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	3,451	$261.20
90723		<1%	60	$250.55
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,154	$238.85
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	659	$230.98
73140		<1%	36	$206.44
H0048	Alcohol and/or other drug testing: collection and handling only, specimens other than blood	<1%	1,049	$202.72
82950		<1%	17	$200.85
G0008	Administration of influenza virus vaccine	<1%	248	$198.73
82627		<1%	13	$196.34
85014		<1%	181	$195.60
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	<1%	66	$188.16
36591		<1%	25	$187.07
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,223	$182.71
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,046	$161.28
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	983	$154.24
90647		<1%	42	$144.30
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	3,053	$143.16
84630		<1%	35	$138.00
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	9,254	$131.11
86334		<1%	31	$130.45
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	476	$126.48
73620		<1%	16	$116.58
73100		<1%	17	$115.03
86308		<1%	16	$114.66
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	855	$111.74
84134		<1%	16	$108.58
82747		<1%	29	$99.62
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	6,660	$98.19
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	1,360	$95.75
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,045	$95.51
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,921	$94.07
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,795	$92.72
85046		<1%	96	$92.33
90472	Immunization administration, each additional vaccine (list separately)	<1%	53	$89.76
85007		<1%	20	$89.52
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	267	$89.41
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	333	$89.00
J2060	Injection, lorazepam, 2 mg	<1%	626	$88.94
93280		<1%	13	$84.98
86255		<1%	16	$84.13
84591		<1%	17	$81.11
82962		<1%	244	$78.97
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	<1%	31	$76.28
84590		<1%	17	$69.98
90734		<1%	44	$67.75
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,699	$65.58
86800		<1%	12	$64.30
36600		<1%	18	$60.06
84252		<1%	14	$58.85
87075		<1%	124	$56.79
C1769	Guide wire	<1%	933	$56.59
74021		<1%	19	$50.16
82010		<1%	26	$48.45
82172		<1%	12	$47.04
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	211	$45.23
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	131	$44.76
84466		<1%	22	$31.58
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	288	$28.02
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	39	$24.85
A6445	Conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard	<1%	55	$24.43
J1940	Injection, furosemide, up to 20 mg	<1%	266	$20.69
J3480	Injection, potassium chloride, per 2 meq	<1%	430	$20.03
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	681	$18.46
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	118	$16.03
A6454	Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard	<1%	485	$14.69
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	705	$13.70
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,312	$13.51
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	758	$13.01
96373		<1%	51	$12.47
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	247	$12.47
J3411	Injection, thiamine hcl, 100 mg	<1%	41	$9.02
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	32	$8.48
88112		<1%	17	$6.81
91300		<1%	827	$6.12
90700		<1%	20	$5.00
J1630	Injection, haloperidol, up to 5 mg	<1%	68	$2.70
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	65	$2.54
99024		<1%	17	$2.41
J2550	Injection, promethazine hcl, up to 50 mg	<1%	13	$2.11
89051		<1%	29	$1.73
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	348	$1.63
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	40	$1.54
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	44	$1.25
J8540	Dexamethasone, oral, 0.25 mg	<1%	20	$1.17
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	127	$0.52
S0164	Injection, pantoprazole sodium, 40 mg	<1%	83	$0.50
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	1,531	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	600	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	22	$0.00
64494		0%	136	$0.00
94761		0%	302	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	395	$0.00
C9399	Unclassified drugs or biologicals	0%	17	$0.00
99156		0%	36	$0.00
J2469	Injection, palonosetron hcl, 25 mcg	0%	75	$0.00
94760		0%	107	$0.00
36430		0%	76	$0.00
01400		0%	19	$0.00
82553		0%	38	$0.00
71101		0%	16	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	29	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	31	$0.00
99173		0%	211	$0.00
96417		0%	76	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	20	$0.00
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	0%	320	$0.00
00812		0%	38	$0.00
88173		0%	46	$0.00
99177		0%	22	$0.00
99188		0%	45	$0.00
01830		0%	41	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	29	$0.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	29	$0.00
64636		0%	21	$0.00
01630		0%	18	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOLMES, TROY (CFO OF UTMC)